Gingko biloba[120]. Conversely, a clinical trial reported no changes to bupropion basic pharmacokinetic parameters in 14 healthy volunteers[121]. In regard to drug efflux, a clinical
study confirmedin vitro evidence that repeated ginkgo administration for 14 days led to
significantly increased talinolol (a P-gp substrate) plasma concentrations in healthy